The Molecular Biochemical and Anatomical Cell Culture Core Laboratory will provide central support to all the projects in the Program. This Core facility will evolve from an already established Core Laboratory which has been part of the Center for Neurodegenerative Diseases. The Core already has extensive capabilities to support histological and molecular biological methods, including qualitative and quantitative in situ hybridization at both the film and emulsion levels, electron microscopy, immunohistochemistry, 3-dimensional anatomical reconstruction (Eutectic), and RT-PCR. Because of the extensive use of cultured human cells in this Program, it will be necessary for the Core to add centralized cell culture facilities to provide cultured human cells in this Program, it will be necessary for the Core to add centralized cell culture facilities to provide for the efficient use of these cells in the four Projects. The Core will be directed by Patricia Trimmer, Ph.D. Dr. Trimmer is an accomplished neuroscientist who already has technical capabilities in all areas of Core support. She will function practically as a Co-Investigator on all three Project, in addition to being P.I. on her own project, and will supervise a Laboratory Specialist Sr. Dr. Parker and Janice Parks (Project 1) will contribute to the Core Lab and participate in the characterization, maintenance and storage of the over 100 cybrid cell lines currently available Together these individuals will interact with all four projects in the following manner: Project 1. Dr. Parker's group will generate the cybrid cell lines from patients' platelet mitochondria and Rho/o SY5Y neuroblastoma and NT2, but these cell lines will be maintained and stored in the Core. Dr. Trimmer will work with Dr. Parker to define anatomically the dynamics of mitochondrial transfer and survival in the cybrid cells. The Core will also be responsible for establishing clonal lines of cybrid cells and will make available to all PI's the different cell lines. Project 2. The Core will provide differentiated cybrids and primary neurons for Dr. Trimmer to use in her studies of mitochondrial dynamics. Project 3. The Core will serve as a source of multiple cybrid cell lines and primary neurons for Dr. Tuttle's group, and will also provide a physical location for some of Dr. Tuttle's experiments to be carried out. Drs. Trimmer and Tuttle will collaborate in establishing biochemical and histological signs of apoptosis in the cybrids. Project 4. The Core will provide multiple cybrid cell lines to Dr. Bennett's group to measure changes in both oxygen free radicals and expression of growth regulatory genes during exposure to mitochondrial toxins. The Core will also support the RT-PCR, histological and in situ hybridization studies in Project 4. Because all cybrid cell lines will be centrally inventoried in the Core, coordination among all PI's as to which individual cell lines are being studied will insure comparability of data. The Core will also have a computing facility to allow efficient record keeping of data collected on cybrids by the PI's.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Virginia
United States
Zip Code
Trimmer, Patricia A; Bennett Jr, James P (2009) The cybrid model of sporadic Parkinson's disease. Exp Neurol 218:320-5
Thiffault, Christine; Bennett Jr, James P (2005) Cyclical mitochondrial deltapsiM fluctuations linked to electron transport, F0F1 ATP-synthase and mitochondrial Na+/Ca+2 exchange are reduced in Alzheimer's disease cybrids. Mitochondrion 5:109-19
Onyango, Isaac G; Tuttle, Jeremy B; Bennett Jr, James P (2005) Altered intracellular signaling and reduced viability of Alzheimer's disease neuronal cybrids is reproduced by beta-amyloid peptide acting through receptor for advanced glycation end products (RAGE). Mol Cell Neurosci 29:333-43
Trimmer, Patricia A; Borland, M Kathleen (2005) Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement. Antioxid Redox Signal 7:1101-9
Onyango, Isaac G; Tuttle, Jeremy B; Bennett Jr, James P (2005) Brain-derived growth factor and glial cell line-derived growth factor use distinct intracellular signaling pathways to protect PD cybrids from H2O2-induced neuronal death. Neurobiol Dis 20:141-54
Onyango, Isaac G; Bennett Jr, James P; Tuttle, Jeremy B (2005) Endogenous oxidative stress in sporadic Alzheimer's disease neuronal cybrids reduces viability by increasing apoptosis through pro-death signaling pathways and is mimicked by oxidant exposure of control cybrids. Neurobiol Dis 19:312-22
Onyango, Isaac G; Tuttle, Jeremy B; Bennett Jr, James P (2005) Activation of p38 and N-acetylcysteine-sensitive c-Jun NH2-terminal kinase signaling cascades is required for induction of apoptosis in Parkinson's disease cybrids. Mol Cell Neurosci 28:452-61
Trimmer, Patricia A; Keeney, Paula M; Borland, M Kate et al. (2004) Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in culture. Neurobiol Dis 15:29-39
Kindler, Dean D; Thiffault, Christine; Solenski, Nina J et al. (2003) Neurotoxic nitric oxide rapidly depolarizes and permeabilizes mitochondria by dynamically opening the mitochondrial transition pore. Mol Cell Neurosci 23:559-73
Dennis, Jameel; Bennett Jr, James P (2003) Interactions among nitric oxide and Bcl-family proteins after MPP+ exposure of SH-SY5Y neural cells II: exogenous NO replicates MPP+ actions. J Neurosci Res 72:89-97

Showing the most recent 10 out of 20 publications